Alpha-1 Antitrypsin Deficiency (AATD)

Explore clinical trials studying Alpha-1 Antitrypsin Deficiency (AATD). Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Alpha-1 Antitrypsin Deficiency (AATD) trial results

Recruiting

NCT07227207

Conditions: Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Clinical Study Center Boston, Massachusetts, United States

Clinical Study Center Charleston, South Carolina, United States

Clinical Study Center Seattle, Washington, United States

Clinical Study Center Fitzroy, Victoria, Australia

Completed

NCT06186492

Conditions: Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Simbec-Orion Clinical Pharmacology, Merthyr Tydfil, Wales, United Kingdom

Completed

NCT07242079

Conditions: Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: University of Parma Parma, Italy

Completed

NCT03679598

Conditions: Alpha-1 Antitrypsin Deficiency (AATD), Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations: The University of Alabama at Birmingham Lung Health Center Birmingham, Alabama, United States

UCLA Los Angeles, California, United States

National Jewish Health Denver, Colorado, United States

Columbia University New York, United States

Active, Not Recruiting

NCT07193615

Conditions: Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Ren Ji Hospital Affiliated to Shanghai Jiao Tong University Shanghai, China